Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Flow from Investing Activities

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cash Flow from Investing Activities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Cash Flow from Investing Activities ₹-3,978 Cr₹-3,212 Cr₹599 Cr₹-1,568 Cr₹-2,903 Cr

What is the latest Cash Flow from Investing Activities ratio of AUROBINDO PHARMA ?

The latest Cash Flow from Investing Activities ratio of AUROBINDO PHARMA is ₹-3,978 Cr based on Mar2023 Consolidated results.
Year Cash Flow from Investing Activities
Mar2023₹-3,978 Cr
Mar2022₹-3,212 Cr
Mar2021₹599 Cr
Mar2020₹-1,568 Cr
Mar2019₹-2,903 Cr

How is Cash Flow from Investing Activities of AUROBINDO PHARMA Trending?

Years Cash Flow from Investing Activities % Change
Mar2023 ₹-3,978 Cr
Negative
Mar2022 ₹-3,212 Cr
Negative
Mar2021 ₹599 Cr
Positive
Mar2020 ₹-1,568 Cr
Negative
Mar2019 ₹-2,903 Cr -

Compare Cash Flow from Investing Activities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,536.7 Cr 4.6% 5.9% 86.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr -0.1% -6.3% 53.5% Stock Analytics
CIPLA ₹115,034.0 Cr 1% -5% 53.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.1% 2.2% 26% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr 3.2% 15.3% 23.6% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 3.9% -1.7% 85.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

4.6%

5.9%

86.7%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses